Suzhou Basecare Medical Corporation Limited (BASECARE-B, 02170) has announced that its Board of Directors will convene on Monday, 30 March 2026. The agenda includes:
• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.
• Authorising the publication of the FY 2025 financial statements.
• Deliberating on the recommendation of a final dividend, if any, for the period under review.
The notice was issued in Suzhou on 18 March 2026 and signed by Chairman and General Manager Dr. Liang Bo. The Board currently consists of eight directors: three executive, two non-executive and three independent non-executive members.